Literature DB >> 8022314

Two phases of pseudopod protrusion in tumor cells revealed by a micropipette.

C Dong1, S Aznavoorian, L A Liotta.   

Abstract

Pseudopod protrusion at the leading edge is a characteristic of migrating tumor cells as they traverse vascular subendothelial basement membranes to establish metastases. A micropipette system has been developed to study the dynamics of pseudopod protrusion in individual human melanoma cells in response to type IV collagen, a component of basement membranes. Soluble type IV collagen stimulates chemotaxis of A2058 melanoma cells through a G protein-coupled receptor, and induces an early burst of intracellular calcium (Savarese et al., 1992, J. Biol. Chem. 267, 21928-21935). A micropipette filled with type IV collagen solution (100 micrograms/ml) was positioned so that the tip was adjacent to a cell suspended in Dulbeceo's modified Eagle's medium. Within 10 min, tumor cells generated a pseudopod which entered the micropipette with an average velocity of 0.24 micron/min and proceeded to lengthen for 40 min. Pseudopods from individual cells ranged from 7.5-10 microns at this time and were characterized by an irregular shape which did not fill the lumen of the micropipette. Pretreatment of cells with pertussis toxin (0.5 microgram/ml), which inhibits cell migration by approximately 90% (but not the calcium burst), blocked formation of the irregular, extended pseudopod, while allowing a much smaller outpouching, or bleb, to form. Lengths of such blebs from individual PT-treated cells reached a plateau at approximately 20 min and ranged from 2.2-4.0 microns at the end point. Treatment of cells with bis-(amino-phenoxy)ethane tetraacetic acid (75 microM), an intracellular Ca2+ chelator, blocked initial bleb formation and prevented extension. From these observations we hypothesize that tumor cell pseudopod protrusion induced by soluble type IV collagen takes place in distinct, separable phases: an initial convex, symmetrical outpouching, caused by localized Ca(2+)-activated actin depolymerization and osmotic flux, followed by an extension with an irregular shape, which requires G protein-mediated actin polymerization.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8022314     DOI: 10.1006/mvre.1994.1005

Source DB:  PubMed          Journal:  Microvasc Res        ISSN: 0026-2862            Impact factor:   3.514


  17 in total

1.  Membrane tether formation from blebbing cells.

Authors:  J Dai; M P Sheetz
Journal:  Biophys J       Date:  1999-12       Impact factor: 4.033

2.  Use of green fluorescent protein-conjugated beta-actin as a novel molecular marker for in vitro tumor cell chemotaxis assay.

Authors:  L Hodgson; W Qiu; C Dong; A J Henderson
Journal:  Biotechnol Prog       Date:  2000 Nov-Dec

3.  In vitro characterization and micromechanics of tumor cell chemotactic protrusion, locomotion, and extravasation.

Authors:  Cheng Dong; Margaret J Slattery; Bradley M Rank; Jun You
Journal:  Ann Biomed Eng       Date:  2002-03       Impact factor: 3.934

4.  Micromechanics of tumor cell adhesion and migration under dynamic flow conditions.

Authors:  Cheng Dong; Margaret Slattery; Shile Liang
Journal:  Front Biosci       Date:  2005-01-01

5.  Integrin VLA-4 enhances sialyl-Lewisx/a-negative melanoma adhesion to and extravasation through the endothelium under low flow conditions.

Authors:  Shile Liang; Cheng Dong
Journal:  Am J Physiol Cell Physiol       Date:  2008-07-16       Impact factor: 4.249

6.  Effects of integrins on laminin chemotaxis by hepatocellular carcinoma cells.

Authors:  Bian-Hong Fu; Ze-Zhi Wu; Jian Qin
Journal:  Mol Biol Rep       Date:  2009-09-21       Impact factor: 2.316

7.  [Ca2+]i as a potential downregulator of alpha2beta1-integrin-mediated A2058 tumor cell migration to type IV collagen.

Authors:  L Hodgson; C Dong
Journal:  Am J Physiol Cell Physiol       Date:  2001-07       Impact factor: 4.249

8.  Extracellular lipid-mediated signaling in tumor-cell activation and pseudopod protrusion.

Authors:  L Hodgson; E C Kohn; C Dong
Journal:  Int J Cancer       Date:  2000-11-15       Impact factor: 7.396

9.  Effects of integrin α6β1 on migration of hepatocellular carcinoma cells.

Authors:  Bian-Hong Fu; Ze-Zhi Wu; Jian Qin
Journal:  Mol Biol Rep       Date:  2011-02-26       Impact factor: 2.316

10.  Targeting mutant (V600E) B-Raf in melanoma interrupts immunoediting of leukocyte functions and melanoma extravasation.

Authors:  Shile Liang; Arati Sharma; Hsin-Hsin Peng; Gavin Robertson; Cheng Dong
Journal:  Cancer Res       Date:  2007-06-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.